These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124. The Relationship Between Vancomycin Trough Concentrations and AUC/MIC Ratios in Pediatric Patients: A Qualitative Systematic Review. Tkachuk S; Collins K; Ensom MHH Paediatr Drugs; 2018 Apr; 20(2):153-164. PubMed ID: 29344778 [TBL] [Abstract][Full Text] [Related]
125. Association of vancomycin serum concentrations with efficacy in patients with MRSA infections: a systematic review and meta-analysis. Steinmetz T; Eliakim-Raz N; Goldberg E; Leibovici L; Yahav D Clin Microbiol Infect; 2015 Jul; 21(7):665-73. PubMed ID: 25887712 [TBL] [Abstract][Full Text] [Related]
126. Innovative approaches to optimizing the delivery of vancomycin in individual patients. Pai MP; Neely M; Rodvold KA; Lodise TP Adv Drug Deliv Rev; 2014 Nov; 77():50-7. PubMed ID: 24910345 [TBL] [Abstract][Full Text] [Related]
127. Antibiotic management of methicillin-resistant Staphylococcus aureus--associated acute pulmonary exacerbations in cystic fibrosis. Fusco NM; Toussaint KA; Prescott WA Ann Pharmacother; 2015 Apr; 49(4):458-68. PubMed ID: 25583881 [TBL] [Abstract][Full Text] [Related]
128. Prediction of Vancomycin Dose for Recommended Trough Concentrations in Pediatric Patients With Cystic Fibrosis. Amin RW; Guttmann RP; Harris QR; Thomas JW J Clin Pharmacol; 2018 May; 58(5):662-665. PubMed ID: 29319843 [TBL] [Abstract][Full Text] [Related] [Previous] [New Search]